Christopher Murphy

About Christopher

Christopher Murphy is biotech/advanced therapies expert who most recently served as Vice President and General Manager of Viral Vector Services at Thermo Fisher Scientific.  Prior to joining Thermo Fisher, Chris was chief operating officer for Brammer Bio, building a best-in-class viral vector services business and general manager for the Sanofi-Genzyme Allston Landing manufacturing site leading an integrated remediation program associated with the consent decree.  Chris has more than 30 years of experience in manufacturing, process development, and product commercialization working in vaccines and therapeutics.  He holds an M.Sc. in biochemistry from New York Medical College, and a B.Sc. in biology from Rutgers University.

See all Board Members